Frade et al, Journal of Immunology, 1997, vol. 159: 5576-5584.* |
Förster, R., et al., “A general method for screening mAbs specific for G-protein coupled receptors as exemplified by using epitope tagged BLRI-transfected 293 cells and solid-phase cell ELISA”, Biochemical and Biophysical Research Communications, 196(3) :1496-1503 (1993). |
Boring, L., et al., “Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis,” Nature, 394 (27) :894-897 (1998). |
Ylä-Herttuala, S., et al., “Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions,”Proc. Natl. Acad. Sci., USA, 88:5252-5256 (1991). |
Taubman, M. B., et al., “JE mRNA Accumulates Rapidly in Aortic Injury and in Platelet-Derived Growth Factor-Stimulated Vascular Smooth Muscle Cells,” Circulation Research 70(2) :314-325 (1992). |
Feng, A., et al., “Red Wine Inhibits Monocyte Chemotactic Protein-1 Expression and Modestly Reduces Neointimal Hyperplasia After Balloon Injury in Cholesterol-Fed Rabbits,” 6Circulation 100:2254-2259 (1999). |
Lukacs, N. W., et al., “Production of Monocyte Chemoattractant Protein-1 and Macrophage Inflammatory Protein-1∝ by Inflammatory Granuloma Fibroblasts,” American Journal of Pathology, 144 (4) :711-718 (1994). |
Koch, A. E., et al., “Enhanced Production of Monocyte Chemoattractant Protein-1 in Rheumatoid Arthritis,” The Jour. of Clin. Invest., 90:772-779 (1992). |
Harigai, M., et al., “Monocyte Chemoattractant Protein-1 (MCP-1) in Inflammatory Joint Diseases and Its Involvement in the Cytokine Network of Rheumatoid Synovium,” Clin. Immun. and Immunopathology, 69(1) :83-91 (1993). |
Villiger, P. M., et al., “Production of Monocyte Chemoattractant Protein-1 by Inflamed Synovial Tissue and Cultured Synoviocytes,” J. Immunol. 149(2) :722-727 (1992). |
Reinecker, H. C. et al., “Monocyte-Chemoattractant Protein 1 Gene Expression in Intestinal Epithelial Cells and Inflammatory Bowel Disease Mucosa,” Gastroenterology, 108(1) :40-50 (1995). |
Nelken N. A., et al., “Monocyte Chemoattractant Protein-1 in Human Atheromatous Plaques,”J. Clin. Invest., 88:1121-1127 (1991). |
Grewal, I. S., et al., “Transgenic Monocyte Chemoattractant Protein-1 (MCP-1) in Pancreatic Islets Produces Monocyte-Rich Insulitis Without Diabetes,” J. Immunol., 159:401-408 (1997). |
Yu, X., et al., “Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholosterolemic primates,” Proc. Natl. Acad. Sci., USA, 89:6953-6957 (1992). |
Berman, J. W., et al., “Localization of Monocyte Chemoattractant Peptide-1 Expression in the Central Nervous System in Experimental Autoimmune Encephalomyelitis and Trauma in the Rat,”J. Immunol., 156:3017-3023 (1996). |
Berman, J. W., et al., “Localization of Monocyte Chemoattractant Peptide-1 Expression in the Central Nervous System in Experimental Autoimmune Encephalomyelitis and Trauma in the Rat,” J. Immunol., 156:3017-3023 (1996). |
Lukacs, N. W., et al., “The Production of Chemotactic Cytokines an Allogeneic Response,” Amer. Jour. of Pathology, 143(4) :1179-1188 (1993). |
Christensen, P. J. et al., “Characterization of the Production of Monocyte Chemoattractant Protein-1 and IL-8 in an Allogeneic Immune Response,” The Journal of Immunology, 151 (3) :1205-1213 (1993). |
Rand, M. L., et al., “Inhibition of T Cell Recruitment and Cutaneous Delayed-Type Hypersensitivity-Induced Inflammation with Antibodies to Monocyte Chemoattractant Protein-1,” Amer. Jour. of Pathology, 148 (3) :855-864 (1996). |
Jones, M. L., and Warren, J. S., “Monocyte Chemoattractant Protein 1 in a Rat Model of Pulmoanry Granulomatosis,” Laboratory Investigation, 66 (4) :498-503 (1992). |
Lloyd, C. M. et al., “Role of MCP-1 and RANTES in inflammation and progession to fibrosis during murine crescentic nephritis,” Journal of Leukocyte Biology, 62: 676-680 (1997). |
Flory, C. M. et al., “Pulmonary Granuloma Formation in the Rat is Partially Dependent on Monocyte Chemoattractant Protein 1,” Laboratory Invest., 69 (4) :396-404 (1993). |
Jones, M. L., et al., “Potential Role of Monocyte Chemoattractant Protein 1/JE In Monocyte/Macrophage-Dependent IgA Immune Complex Alveolitis in the Rat,” J. Immunol., 149 (6) :2147-2154 (1992). |
Gu, L. et al., “Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor-Deficient Mice,” Molecular Cell, 2 (2) :275-281 (1998). |
Lu, B., et al., “Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1-deficient Mice,” J. Exp. Med., 187 (4) :601-608 (1998). |
Rutledge, B. J., et al., “High Level Monocyte Chemoattractant Protein-1 Expression in Transgenic Mice Increases Their Susceptibility to Intracelluar Pathogens,” J. Immunol., 155:4838-4843 (1995). |
Gunn, M. D. et al., “Monocyte Chemoattractant Protein-1 Is Sufficient for the Chemotaxis of Monocytes and Lymphoctyes in Transgenic Mice but Requires an Additional Stimulus for Inflammatory Activation,” J. Immunol., 158::376-383 (1997). |
Chensue, S. W., et al., “Role of Monocyte Chemoattractant Protein-1 (MCP-1) in Th1 (Mycobacterial) and Th2 (Schistosomal) Antigen-Induced Granuloma Formation,” J. Immunol. 157:4602-4608 (1996). |
Lukacs, N. W., et al., “Differential Recruitment of Leukocyte Populations and Alteration of Airway Hyperreactivity by C-C Family Chemokines in Allergic Airway Inflammation,” J. Immunol., 158:4398-4404 (1997). |
Tang, W. W. et al., “Chemokine Expression in Experimental Tubulointerstitial Nephritis,” J. Immunol. 159:870-876 (1997). |
Fujinaka, H. et al., “Suppression of Anti-Glomerular Basement Membrane Nephritis by Adminstration of Anti-Monocyte Chemoattractant Protein 1 Antibody in WKY Rats,” Jour. of the Amer. Soc. of Nephrology, 8:1174-1178 (1997). |
Lloyd, C. M., et al., “RANTES and Monocyte Chemoattractant Protein-1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis,” J. of Exp. Med., 185 (7) :1371-1380 (1997). |
Furukawa, Y., et al., “Anti-Monocyte Chemoattractant Protein-1/Monocyte Chemotactic and Activating Factor Antibody Inhibits Neointimal Hyperplasia in Injured Rat Carotid Arteries,” Circulation Research, 84:306-314 (1999). |
Zisman, D. A. et al., “MCP-1 Protects Mice in Lethal Endotoxemia,” J. Clin. Invest., 99(12) :2832-2836 (1997). |
Schimmer, R. C., et al., “Streptococcal Cell Wall-Induced Arthritis: Requirements for IL-4, IL-10, IFN-γ, and Monocyte Chemoattractant Protein-1, ” J. Immunol., 160:1466-1471 (1998). |
Ogata, H., et al., “The Role of Monocyte Chemoattractant Protein-1 (MCP-1) in the Pathogenesis of Collagen-Induced Arthritis in Rats,” J. Pathol., 182:106-114 (1997). |
Huffnagle, G. B., et al., “The Role of Monocyte Chemotactic Protein-1 (MCP-1) Inhibits Arthritis in the MRL-1pr Mouse Model,” J. Exp. Med., 186 (1) :131-137 (1997). |
Gong, J., et al., “An Antagonist of Monocyte Chemoattractant Protein 1 (MCP-1) Inhibits Arthritis in the MRL-1pr Mouse Model,” J. Exp. Med., 186 (1) :131-137 (1997). |
Boring, L., et al., “Impaired Monocyte Migration and Reduced Type 1 (Th1) Cytokine Responses in C-C Chemokine Receptor 2 Knockout Mice,” J. Clin. Invest., 100(10) :2552-2561 (1997). |
Kuziel, W. A., et al., “Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2,” Proc. Natl. Acad. of Sci., USA 94(22) :12053-12058 (1997). |
Kurihara, T., et al., “Defects in Macrophage Recruitment and Host Defense in Mice Lacking the CCR2 Chemokine Receptor,” J. Exp. Med., 186 (10) :1757-1762 (1997). |
Jiang, Y., et al., “Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis,” J. Neuroimmunology, 86:1-12 (1998). |
Chuntharapai, et al., “Generation of Monoclonal Antibodies to Chemokine Receptors”, Methods in Enzymology288:15-27 (1997). |
Monteclaro, F. S. and Charo, I. F., “The Amino-terminal Domain of CCR2 Is Both Necessary and Sufficient for High Affinity Binding of Monocyte Chemoattractant Protein 1” The Journal of Biological Chemistry, 272(37):23186-23190 (1997). |
Qin, Shixin, et al., “Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential,” Eur. J. Immonol., 26:640-647 (1996). |
Yamagami, Shinsuke, et al., “cDNA Cloning and Functional Expression of a Human Monocyte Chemoattractant Protein 1 Receptor,” Biochemical and Biophysical Research Communications, 202 (2) :1156-1162 (1994). |
Charo, Israel, F., et al., “Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails,” Proc. Natl. Acad. Sci., USA., 91:2752-2756 (1994). |
Aragay, A. M., et al., “Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2,” Proc. Natl. Acad. Sci., USA, 95:2985-2990 (1998). |
Frade, Jose M. R., et al., “The Amino-Terminal Domain of the CCR2 Chemokine Receptor Acts as Coreceptor for HIV-1 Infection,” J. Clin. Invest., 100(3) :497-502 (1997). |
Wong, Lu-Min, et al., “Organization and Differential Expression of the Human Monocyte Chemoattraction Protein 1 Receptor Gene,” The Journal of Biological Chemistry,272 (2):1038-1045 (1987). |
Kurihara, Takao and Bravo, Rodrigo, “Cloning and Functional Expression of mCCR2, a Murine Receptor for the C-C Chemokines JE and FIC,” The Journal of Biological Chemistry, 271(20) :11603-11606 (1996). |
Grimm, M. C., et al., “Enchanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa,” Journal of Leukocyte Biology59:804-812 (1996). |
Izikson L., et al., “Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the CC Chemokine Receptor (CCR) 2,” J.Exp. Med., 192(7) :1075-1080 (2000). |
Fife, B. T. et al., “CC Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis,” J. Exp. Med., 192 (6) :899-905 (2000). |
Sanz, I., et al. “Evidence That Autoantibodies Can Be Unmutated Copies of Germline Genes,” The Journal of Immunology142 (3) :883-887 (1989). |
Chastagner, P., et al., “Cloning of a gene encoding a lupus-associated human autoantibody Vk region using the polymerase chain reaction and degenerate primers,”Gene 101:305-306 (1989). |
Chothia, C., et al., “Conformations of immunoglobulin hypervariable regions,” Nature342:877-883 (1989). |
Welt, et al., “Targeting CCR-2 or CD18 Inhibits Experimental in-Stent Restenosis in Primates. Inhibitory Potential Depends on Type of Injury and Leukocytes Targeted”, Circulation-Journal of the American Heart Association (Abstracts from Scientific Sessions 2000), 102(18) : II-247, Abstract 1206 (2000). |